The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Merck Serono
Consulting or Advisory Role - Amgen; Lilly
Travel, Accommodations, Expenses - Amgen; SERVIER
Overall survival prognosis of patients in immuno-oncology phase I trials: The Gustave Roussy score.
 
Frederic Bigot
No Relationships to Disclose
 
Eduardo Castanon
No Relationships to Disclose
 
Capucine Baldini
No Relationships to Disclose
 
Sandrine Aspeslagh
Honoraria - AstraZeneca; Bristol-Myers Squibb
 
Aurelien Marabelle
Honoraria - Bristol-Myers Squibb; Genentech; Merck; Roche
Consulting or Advisory Role - Amgen; Genentech; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Roche
Research Funding - Merus (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Christophe Massard
Honoraria - Astellas Oncology; Genentech; Ipsen; Janssen; MedImmune; Orion; Sanofi
Consulting or Advisory Role - Astellas Oncology; Genentech; Ipsen; Janssen; MedImmune; Orion; Sanofi
 
Antoine Hollebecque
No Relationships to Disclose
 
Sophie Postel-Vinay
No Relationships to Disclose
 
Jean-Charles Soria
Honoraria - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; GamaMabs Pharma; GlaxoSmithKline; Lilly; Merus; Mission Therapeutics; MSD; Pfizer; PharmaMar; Pierre Fabre; Roche; Sanofi; SERVIER; Symphony Evolution; Takeda
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; GamaMabs Pharma; GlaxoSmithKline; Lilly; Merus; Mission Therapeutics; MSD; Pfizer; PharmaMar; Pierre Fabre; Roche; Sanofi; SERVIER; Symphony Evolution; Takeda